Early research (Phase 1)Study completedNCT01065558
What this trial is testing
Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease
Who this might be right for
Lesch-Nyhan Disease
Psyadon Pharma 5